NI-2901, a CD47xPD-L1 bispecific antibody for dual immune checkpoint blockade with finetuned affinity to reduce erythrocyte binding and improve biodistribution
CANCER RESEARCH(2022)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined